If you’ve encountered confusion while diagnosing and treating Cutaneous T-Cell Lymphoma, you will likely find your answers in this dynamic discussion featuring Dermcast.live host Rob Casquejo, PA-C, and Heather Woodworth Goff, MD, MPH, of UT Southwestern. Relying on her comprehensive expertise, Dr. Goff sheds light on identifying instances where Cutaneous T-Cell Lymphoma might be mistaken …
Ted Rosen, MD, began his lecture on itchy dermatoses by defining itch as “the unpleasant sensation which evokes the desire to scratch.” While histamine can be a major driver of itch, there are numerous others including neuropeptides, proteases, cytokines, substance P, therefore, it is important to consider the addition of other agents beyond antihistamines to …
Stop living in auto mode, see others and find common ground Storyteller, speaker, author and Nashville resident, Carlos Whittaker helped kick off the SDPA 21st Annual Fall Dermatology Conference Thursday with the theme, How to Human, based on his book. He mesmerized the audience by sharing his personal experience of being the parent of a …
Fresh off the stage at SDPA’s summer conference in Boston, Cynthia Griffith, MPAS, PA-C, and Peter Young, MPAS, PA-C, enter the Dermcast.live studio to share highlights of their presentation on peer reviewed literature with host Rob Casquejo, PA-C. Griffith, Editor in Chief of JDPA, and Young, a JDPA Editorial Board member, are perfectly suited to …
Cristy Garza-Mayers, MD, PhD, a pediatric dermatologist at Massachusetts General Hospital, reviewed eczema in patients under 12 at SDPA’s Summer Conference in Boston. Dr. Garza-Mayers initiated her talk with an overview of the pathophysiology of atopic dermatitis (AD). The presentation of eczema tends to vary in distribution with the age of the patient. Morphologies associated …
Dermcast.live host Hope Cook, PA-C, engages Dr. Stephen Tyring in an interesting conversation about dermatological conditions for which off-label use of medications are helpful (e.g., warts and autoimmune blistering diseases). Dr. Tyring also guides listeners through situations in which off-label use is the only reasonable choice (e.g., no on-label medications exist, insurance does not cover …